Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function

NCT07076030 is registered in ClinicalTrials.gov with Zealand Pharma as lead sponsor.

NCT NCT07076030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07076030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function
Lead sponsor
Zealand Pharma
Phase
Phase 1
Overall status
Completed
Start date
April 15, 2025
Completion date
November 25, 2025
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal impairment